
    
      Eligible patients will be randomized to one of the two treatment groups. Group 1 patients
      will receive 30 mg of Trospium chloride tablet twice daily, while group 2 patients will
      receive 0.4 mg of Tamsulosin tablet once daily, until the stent is removed. Ureteral Stent
      Symptoms Questionnaire (USSQ) will be used to evaluate the symptoms of the patients with DJ
      stent after 2 weeks of inserting the stent.
    
  